• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通心络在缺氧和血清剥夺条件下通过AMPK/eNOS途径浓度依赖性地减少间充质干细胞的凋亡。

Tongxinluo decreases apoptosis of mesenchymal stem cells concentration-dependently under hypoxia and serum deprivation conditions through the AMPK/eNOS pathway.

作者信息

Li Na, Yang Yue-Jin, Cui He-He, Zhang Qian, Jin Chen, Qian Hai-Yan, Dong Qiu-Ting, Zhang Hao

机构信息

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

出版信息

J Cardiovasc Pharmacol. 2014 Mar;63(3):265-73. doi: 10.1097/FJC.0000000000000044.

DOI:10.1097/FJC.0000000000000044
PMID:24220313
Abstract

Tongxinluo (TXL), a traditional Chinese medicine, is widely used to treat cardiovascular diseases in China. Our previous study has demonstrated the pro-survival role of TXL on mesenchymal stem cells (MSCs) in vivo. But whether TXL could decrease apoptosis of MSCs in vitro, and the underlying mechanism are still unknown. Moreover, AMPK/eNOS pathway is crucial in regulating cell apoptosis. Therefore, we designed the study to investigate whether TXL could decrease MSCs apoptosis under hypoxia and serum deprivation (H/SD) conditions and to determine the role of AMPK/eNOS pathway. To test the hypothesis, MSCs were treated with TXL (50-400 μg/mL) under H/SD for 6 hours. For inhibitor studies, the cells were preincubated with AMPK inhibitor compound C. Results indicated that TXL decreased MSCs apoptosis concentration-dependently evidenced by reduced Annexin V+/PI- cells and increased red/green ratio of JC-1. Further, TXL enhanced the phosphorylation of AMPK and eNOS. Whereas, treatment with compound C decreased the phosphorylation of AMPK and eNOS and was accompanied by attenuated anti-apoptotic effect of TXL. In conclusion, TXL protected MSCs against H/SD-induced injury at least in part through the AMPK/eNOS pathway, which provides a novel explanation for the multi-effect of TXL on cardiovascular system.

摘要

通心络(TXL)是一种中药,在中国被广泛用于治疗心血管疾病。我们之前的研究已经证明了通心络在体内对间充质干细胞(MSCs)具有促生存作用。但是通心络是否能在体外减少间充质干细胞的凋亡以及潜在机制仍不清楚。此外,AMPK/eNOS通路在调节细胞凋亡中起关键作用。因此,我们设计了本研究,以探讨通心络在缺氧和血清剥夺(H/SD)条件下是否能减少间充质干细胞的凋亡,并确定AMPK/eNOS通路的作用。为了验证这一假设,将间充质干细胞在H/SD条件下用通心络(50 - 400μg/mL)处理6小时。对于抑制剂研究,细胞先用AMPK抑制剂化合物C进行预孵育。结果表明,通心络以浓度依赖性方式减少间充质干细胞凋亡,这通过Annexin V+/PI-细胞减少和JC-1红绿比值增加得以证明。此外,通心络增强了AMPK和eNOS的磷酸化。然而,用化合物C处理降低了AMPK和eNOS的磷酸化,并伴随着通心络抗凋亡作用的减弱。总之,通心络至少部分通过AMPK/eNOS通路保护间充质干细胞免受H/SD诱导的损伤,这为通心络对心血管系统的多重作用提供了新的解释。

相似文献

1
Tongxinluo decreases apoptosis of mesenchymal stem cells concentration-dependently under hypoxia and serum deprivation conditions through the AMPK/eNOS pathway.通心络在缺氧和血清剥夺条件下通过AMPK/eNOS途径浓度依赖性地减少间充质干细胞的凋亡。
J Cardiovasc Pharmacol. 2014 Mar;63(3):265-73. doi: 10.1097/FJC.0000000000000044.
2
Tongxinluo exerts protective effects via anti-apoptotic and pro-autophagic mechanisms by activating AMPK pathway in infarcted rat hearts.通心络通过激活梗死大鼠心脏中的AMPK途径,经由抗凋亡和促自噬机制发挥保护作用。
Exp Physiol. 2017 Apr 1;102(4):422-435. doi: 10.1113/EP086192. Epub 2017 Mar 14.
3
Atorvastatin prevents mesenchymal stem cells from hypoxia and serum-free injury through activating AMP-activated protein kinase.阿托伐他汀通过激活 AMP 激活的蛋白激酶来防止骨髓间充质干细胞缺氧和无血清损伤。
Int J Cardiol. 2011 Dec 15;153(3):311-6. doi: 10.1016/j.ijcard.2010.08.047. Epub 2010 Sep 15.
4
Tongxinluo reduces myocardial no-reflow and ischemia-reperfusion injury by stimulating the phosphorylation of eNOS via the PKA pathway.通心络通过激活蛋白激酶 A 通路促进内皮型一氧化氮合酶磷酸化,减少心肌无复流及缺血再灌注损伤。
Am J Physiol Heart Circ Physiol. 2010 Oct;299(4):H1255-61. doi: 10.1152/ajpheart.00459.2010. Epub 2010 Aug 6.
5
[Atorvastatin protects swine bone marrow mesenchymal stem cells from apoptosis through AMPK but not PI3K/Akt pathway].阿托伐他汀通过AMPK途径而非PI3K/Akt途径保护猪骨髓间充质干细胞免于凋亡
Zhonghua Xin Xue Guan Bing Za Zhi. 2011 Nov;39(11):1033-8.
6
Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats.二甲双胍通过激活 AMP 激活的蛋白激酶-内皮型一氧化氮合酶通路减轻大鼠心室肥厚。
Clin Exp Pharmacol Physiol. 2011 Jan;38(1):55-62. doi: 10.1111/j.1440-1681.2010.05461.x.
7
Induction of autophagy by Tongxinluo through the MEK/ERK pathway protects human cardiac microvascular endothelial cells from hypoxia/reoxygenation injury.通心络通过MEK/ERK途径诱导自噬可保护人心脏微血管内皮细胞免受缺氧/复氧损伤。
J Cardiovasc Pharmacol. 2014 Aug;64(2):180-90. doi: 10.1097/FJC.0000000000000104.
8
Autophagy activation: a novel mechanism of atorvastatin to protect mesenchymal stem cells from hypoxia and serum deprivation via AMP-activated protein kinase/mammalian target of rapamycin pathway.自噬激活:阿托伐他汀通过 AMP 激活的蛋白激酶/雷帕霉素靶蛋白通路保护骨髓间充质干细胞免受低氧和血清剥夺损伤的新机制。
Stem Cells Dev. 2012 May 20;21(8):1321-32. doi: 10.1089/scd.2011.0684. Epub 2012 Mar 28.
9
Lovastatin protects mesenchymal stem cells against hypoxia- and serum deprivation-induced apoptosis by activation of PI3K/Akt and ERK1/2.洛伐他汀通过激活PI3K/Akt和ERK1/2保护间充质干细胞免受缺氧和血清剥夺诱导的细胞凋亡。
J Cell Biochem. 2008 Jan 1;103(1):256-69. doi: 10.1002/jcb.21402.
10
Protein kinase A-mediated cardioprotection of Tongxinluo relates to the inhibition of myocardial inflammation, apoptosis, and edema in reperfused swine hearts.蛋白激酶 A 介导的通心络心肌保护作用与抑制再灌注猪心肌炎症、凋亡和水肿有关。
Chin Med J (Engl). 2013;126(8):1469-79.

引用本文的文献

1
Clinical effects and mechanisms of a Chinese patent medicine, Tongxinluo capsule, as an adjuvant treatment in coronary heart disease.一种中成药通心络胶囊作为冠心病辅助治疗的临床疗效及机制
Heliyon. 2024 Mar 6;10(6):e27460. doi: 10.1016/j.heliyon.2024.e27460. eCollection 2024 Mar 30.
2
Intervention effects of traditional Chinese medicine on stem cell therapy of myocardial infarction.中药对心肌梗死干细胞治疗的干预作用
Front Pharmacol. 2022 Oct 18;13:1013740. doi: 10.3389/fphar.2022.1013740. eCollection 2022.
3
Ginsenoside Rh2 Inhibits NLRP3 Inflammasome Activation and Improves Exosomes to Alleviate Hypoxia-Induced Myocardial Injury.
人参皂苷 Rh2 抑制 NLRP3 炎性小体激活并改善外泌体缓解低氧诱导的心肌损伤。
Front Immunol. 2022 Jul 5;13:883946. doi: 10.3389/fimmu.2022.883946. eCollection 2022.
4
Tongxinluo-pretreated mesenchymal stem cells facilitate cardiac repair via exosomal transfer of miR-146a-5p targeting IRAK1/NF-κB p65 pathway.通心络预处理间充质干细胞通过外泌体转移 miR-146a-5p 靶向 IRAK1/NF-κB p65 通路促进心脏修复。
Stem Cell Res Ther. 2022 Jul 7;13(1):289. doi: 10.1186/s13287-022-02969-y.
5
Sequential transplantation of exosomes and mesenchymal stem cells pretreated with a combination of hypoxia and Tongxinluo efficiently facilitates cardiac repair.序贯移植缺氧预处理联合通心络的间充质干细胞外泌体可有效促进心脏修复。
Stem Cell Res Ther. 2022 Feb 7;13(1):63. doi: 10.1186/s13287-022-02736-z.
6
Mapping current research and identifying hotspots on mesenchymal stem cells in cardiovascular disease.绘制当前研究图谱并确定心血管疾病间充质干细胞的热点。
Stem Cell Res Ther. 2020 Nov 25;11(1):498. doi: 10.1186/s13287-020-02009-7.
7
Tongxinluo attenuates oxygen-glucose-serum deprivation/restoration-induced endothelial barrier breakdown via peroxisome proliferator activated receptor-α/angiopoietin-like 4 pathway in high glucose-incubated human cardiac microvascular endothelial cells.通心络通过过氧化物酶体增殖物激活受体-α/血管生成素样4通路减轻高糖培养的人心脏微血管内皮细胞中氧-葡萄糖-血清剥夺/复氧诱导的内皮屏障破坏。
Medicine (Baltimore). 2020 Aug 21;99(34):e21821. doi: 10.1097/MD.0000000000021821.
8
1,25(OH)D Strengthens the Vasculogenesis of Multipotent Mesenchymal Stromal Cells from Rat Bone Marrow by Regulating the PI3K/AKT Pathway.1,25(OH)D 通过调节 PI3K/AKT 通路增强大鼠骨髓间充质干细胞的血管生成。
Drug Des Devel Ther. 2020 Mar 16;14:1157-1167. doi: 10.2147/DDDT.S222244. eCollection 2020.
9
Inhibition of miR-128-3p by Tongxinluo Protects Human Cardiomyocytes from Ischemia/reperfusion Injury via Upregulation of p70s6k1/p-p70s6k1.通心络抑制miR-128-3p通过上调p70s6k1/p-p70s6k1保护人心肌细胞免受缺血/再灌注损伤。
Front Pharmacol. 2017 Oct 30;8:775. doi: 10.3389/fphar.2017.00775. eCollection 2017.
10
Tongxinluo inhibits neointimal formation by regulating the expression and post-translational modification of KLF5 in macrophages.通心络通过调节巨噬细胞中KLF5的表达和翻译后修饰来抑制内膜增生。
Am J Transl Res. 2016 Nov 15;8(11):4778-4790. eCollection 2016.